Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parry

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
Molecular Biology of the Cell|February 4, 2011
Regulation of flagellar motility by the conserved flagellar protein CG34110/Ccdc135/FAP50Yong Yang, Deborah A Cochran, Mary D Gargano, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 9, 1998
Effect of iron chelation therapy on mortality in Zambian children with cerebral malariaP E Thuma, G F Mabeza, G Biemba, et al.
Frontiers in Sports and Active Living|July 25, 2022
Imposing Compulsory Rugby Union on Schoolchildren: An Analysis of English State-Funded Secondary SchoolsAdam John White, John Batten, Nathan E Howarth, et al.
Nucleic Acid Therapeutics|July 20, 2012
Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendationsEric W Alton, Homer A Boushey, Holger Garn, et al.
Nucleic Acid Therapeutics|January 23, 2025
Opportunities for More Tailored Approaches to Genotoxicity Testing and Carcinogenicity Strategy for Oligonucleotide Therapeutics: Outcome of an Industry SurveyJoel D Parry, Tod A Harper, Patrik Andersson, et al.
Chemical Research in Toxicology|April 3, 2009
Pivotal role for two electron reduction in 2,3-dimethoxy-1,4-naphthoquinone and 2-methyl-1,4-naphthoquinone metabolism and kinetics in vivo that prevents liver redox stressJoel D Parry, Amy V Pointon, Ursula Lutz, et al.
American Journal of Human Genetics|August 1, 1996
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of diseaseM H Ruttledge, A A Andermann, C M Phelan, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense DrugsPiotr J Kamola, Klio Maratou, Paul A Wilson, et al.
Nucleic Acids Research|September 5, 2015
In silico and in vitro evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimizationPiotr J Kamola, Jeremy D A Kitson, Gemma Turner, et al.
PLOS Global Public Health|March 24, 2023
Benchmarking alcohol policy based on stringency and impact: The International Alcohol Control (IAC) policy indexSally Casswell, Taisia Huckle, Karl Parker, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
Molecular Biology of the Cell|February 4, 2011
Regulation of flagellar motility by the conserved flagellar protein CG34110/Ccdc135/FAP50Yong Yang, Deborah A Cochran, Mary D Gargano, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 9, 1998
Effect of iron chelation therapy on mortality in Zambian children with cerebral malariaP E Thuma, G F Mabeza, G Biemba, et al.
Frontiers in Sports and Active Living|July 25, 2022
Imposing Compulsory Rugby Union on Schoolchildren: An Analysis of English State-Funded Secondary SchoolsAdam John White, John Batten, Nathan E Howarth, et al.
Nucleic Acid Therapeutics|July 20, 2012
Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendationsEric W Alton, Homer A Boushey, Holger Garn, et al.
Nucleic Acid Therapeutics|January 23, 2025
Opportunities for More Tailored Approaches to Genotoxicity Testing and Carcinogenicity Strategy for Oligonucleotide Therapeutics: Outcome of an Industry SurveyJoel D Parry, Tod A Harper, Patrik Andersson, et al.
Chemical Research in Toxicology|April 3, 2009
Pivotal role for two electron reduction in 2,3-dimethoxy-1,4-naphthoquinone and 2-methyl-1,4-naphthoquinone metabolism and kinetics in vivo that prevents liver redox stressJoel D Parry, Amy V Pointon, Ursula Lutz, et al.
American Journal of Human Genetics|August 1, 1996
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of diseaseM H Ruttledge, A A Andermann, C M Phelan, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense DrugsPiotr J Kamola, Klio Maratou, Paul A Wilson, et al.
Nucleic Acids Research|September 5, 2015
In silico and in vitro evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimizationPiotr J Kamola, Jeremy D A Kitson, Gemma Turner, et al.
PLOS Global Public Health|March 24, 2023
Benchmarking alcohol policy based on stringency and impact: The International Alcohol Control (IAC) policy indexSally Casswell, Taisia Huckle, Karl Parker, et al.
Pageof 30